Eczemas in the elderly often arise mysteriously and itch furiously. New-onset, otherwise unexplained eczema that cannot be attributed to atopic disease, irritant or allergic contact dermatitis ...

The Medicines and Healthcare products Regulatory Agency has approved the medicine delgocitinib (Anzupgo) to treat severe ...

LEO Pharma has gained marketing authorisation from the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) for ...

Background Hand eczema is common in the general population and affects women twice as often as men. It is also the most frequent occupational skin disease. The economic consequences are ...

“The odds of eczema increased with greater PM2.5 concentration in our large, diverse, adult American cohort. Ambient air pollution is an environmental hazard that influences inflammatory skin ...

This article discusses the treatment options for severe eczema in adults and children. Individuals with eczema may experience mild symptoms. However, the condition can be chronic and cause ...

Department of Dermatology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China Aims: The study aims to explore the associations ...

"Cod liver oil, in particular, is also rich in retinol, which is a type of vitamin A that is fat-soluble and an important ...

AnaptysBio will end the development of its experimental drug to treat eczema as the treatment failed to meet the goals of a ...

Eczema is now a worldwide epidemic. In the UK up to one-fifth of school-age children and one in 12 adults suffer from it. It is itchy, painful and often unsightly, reduces the quality of life and ...

When conventional treatments for moderate to severe atopic dermatitis become less effective, targeted therapies may help.

Anzupgo (delgocitinib) 20mg/g cream is intended to treat moderate to severe chronic hand eczema in adults. Credit: Kmpzzz/Shutterstock. Leo Pharma has gained marketing authorisation from the UK’s ...